ADDRESSing the clinical need for objective pain assessment

CLINICAL NEED

There are currently no clinically accepted tools to objectively assess pain.  Clinicians must rely on patients’ subjective assessments, or simply guess when patients can’t communicate.

NOL™ INDEX TECHNOLOGY

NOL™ (Nociception level) Index, is the only pain assessment index based on dozens of pain-related physiological parameters and clinically validated as superior to other nociception/pain indicators 1,2.  

PMD-200™ System

The PMD-200™ is a monitoring device. Based on the patented NOL™ technology, the PMD-200 provides objective, non-invasive, and continuous monitoring of the physiological response to pain.

TREATING PAIN IS AT THE HEART OF MEDICINE

THE ABILITY TO OBJECTIVELY ASSESS PAIN WILL TOUCH THE LIVES OF EACH OF US

Worldwide are affected by pain 3.

Of doctors’ visits are pain related 4.

U.S. pain associated annual healthcare costs 4.

ABOUT MEDASENSE

Medasense develops innovative systems and applications to objectively assess the physiological response to pain, providing insight throughout the pain management process for accurate and personalized pain care. Medasense’s innovative technology platform acquires, processes and analyzes dozens of physiological parameters, transforming them into a single index by using artificial intelligence algorithms. The clinically validated technology is superior to existing pain indicators 1,2.

Medasense-benefits-homepage

"I truly believe in the NOL technology. I am convinced it will improve the quality of our anesthesia and impact on patients' recovery"

Prof. Philippe Richebé, Professor and Anesthesiologist at Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, Canada. Principal Investigator.

PMD-200TM is CE marked. In the USA limited by federal law to investigational use only.  

References:

  1. Intraoperative validation of the NOL Index, a non-invasive nociception monitor. Ruth Edry, Vasile Recea, Yuri Dikust, Daniel I. Sessler. Anesthesiology July 2016, Vol.125, 193-203
  2. Ability of the Nociception Level (NOL), a multiparameter composite of autonomic signals, to detect noxious stimuli during propofol-remifentanil anesthesia. Chris H. Martini, Martijn Boon, Suzanne J. L. Broens, Evelien F. Hekkelman, Lisanne A. Oudhoff, Anna Willemijn Buddeke, Albert Dahan. Anesthesiology Sept. 2015, Vol.123, 524-534
  3. Painmed.org
  4. Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education: Relieving Pain in America, A Blueprint for Transforming Prevention, Care, Education and Research. The National Academies Press, 2011.